Expression of cardiac function genes in adult stem cells is increased by treatment with nitric oxide agents

Biochemical and Biophysical Research Communications

Volumn 378, Issue 3, 2009, Pages 456-461

  Rebelatto, Carmen K ^a   Aguiar, Alessandra M ^b,c   Senegaglia, Alexandra C ^a   Aita, Carlos M ^a   Hansen, Paula ^a   Barchiki, Fabiane ^a   Kuligovski, Crisciele ^b,c   Olandoski, Márcia ^a   Moutinho, José A ^a   Dallagiovanna, Bruno ^b,c   Goldenberg, Samuel ^b,c   Brofman, Paulo S ^a   Nakao, Lia S ^a   Correa, Alejandro ^b,c  

^a PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^b INSTITUTO CARLOS CHAGAS   (Brazil)

^c Instituto de Biologia Molecular do Parana   (Brazil)

Author keywords

Differentiation; Mesenchymal stem cells; Muscle markers; Nitric oxide; VEGF

Indexed keywords

2 (N,N DIETHYLAMINO)DIAZENOLATE 2 OXIDE; CYCLIC GMP; MESSENGER RNA; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADIPOSE TISSUE; ADULT STEM CELL; ARTICLE; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HEART FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ADULT STEM CELLS; AGED; ANTIGENS, CD; CARDIOMYOPLASTY; CELL DIFFERENTIATION; CELLS, CULTURED; CONNEXIN 43; GENE EXPRESSION; GENETIC MARKERS; HEART; HUMANS; HYDRAZINES; MESENCHYMAL STEM CELLS; MIDDLE AGED; MULTIPOTENT STEM CELLS; MUSCLE PROTEINS; MYOCYTES, CARDIAC; NITRIC OXIDE; NITRIC OXIDE DONORS; PENICILLAMINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 57749171376     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.11.061     Document Type: Article

References (42)

1. Shepler S.A., and Patel A.N. Cardiac cell therapy: a treatment option for cardiomyopathy. Crit. Care Nurs. Q 30 (2007) 74-80
2. Strauer B.E., Brehm M., and Schannwell C.M. The therapeutic potential of stem cells in heart disease. Cell Prolif. 41 Suppl. 1 (2008) 126-145
3. Yoon Y.S., Wecker A., Heyd L., Park J.S., Tkebuchava T., Kusano K., Hanley A., Scadova H., Qin G., Cha D.H., Johnson K.L., Aikawa R., Asahara T., and Losordo D.W. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J. Clin. Invest. 115 (2005) 326-338
4. Jiang Y., Vaessen B., Lenvik T., Blackstad M., Reyes M., and Verfaillie C.M. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp. Hematol. 30 (2002) 896-904
5. Toma C., Pittenger K.S., Cahill K.S., Byrne B.J., and Kessler P.D. Human mesenchymal stem cells differentiate of a cardiomyocyte phenotype in the adult murine heart. Circulation 105 (2002) 93-98
6. Kruglyakov P.V., Sokolova I.B., Zin'kova N.N., Viide S.K., Aleksandrov G.V., Petrov N.S., and Polyntsev D.G. In vitro and in vivo differentiation of mesenchymal stem cells in the cardiomyocyte direction. Bull. Exp. Biol. Med. 142 (2006) 503-506
7. Antonitsis P., Ioannidou-Papagiannaki E., Kaidoglou A., and Papakonstantinou C. In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azacytidine. Interact. Cardiovasc. Thorac. Surg. 6 (2007) 593-597
8. Wang T., Xu Z., Jiang W., and Ma A. Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int. J. Cardiol. 109 (2006) 74-81
9. Nishiyama N., Miyoshi S., Hida N., Uyama T., Okamoto K., Ikegami Y., Miyado K., Segawa K., Terai M., Sakamoto M., Ogawa S., and Umezawa A. The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro. Stem Cells 25 (2007) 2017-2024
10. Shim W.S., Jiang S., Wong P., Tan J., Chua Y.L., Tan Y.S., Sin Y.K., Lim C.H., Chua T., Teh M., Liu T.C., and Sim E. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem. Biophys. Res. Commun. 324 (2004) 481-488
11. Xie X.J., Wang J.A., Cao J., and Zhang X. Differentiation of bone marrow mesenchymal stem cells induced by myocardial medium under hypoxic conditions. Acta Pharmacol. Sin. 27 (2006) 1153-1158
12. Moncada S. Nitric oxide: discovery and impact on clinical medicine. J. R. Soc. Med. 92 (1999) 164-169
13. Covacu R., Danilov A.I., Rasmussen B.S., Hallén K., Moe M.C., Lobell A., Johansson C.B., Svensson M.A., Olsson T., and Brundin L. Nitric oxide exposure diverts neural stem cell fate from neurogenesis towards astrogliogenesis. Stem Cells 24 (2006) 2792-2800
14. Liu Z., Jiang Y., Hao H., Gupta K., Xu J., Chu L., McFalls E., Zweier J., Verfaillie C., and Bache R.J. Endothelial nitric oxide synthase is dynamically expressed during bone marrow stem cell differentiation into endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H1760-H1765
15. Chu L., Jiang Y., Hao H., Xia Y., Xu J., Liu Z., Verfaillie C.M., Zweier J.L., and Liu Z. Nitric oxide enhances Oct-4 expression in bone marrow stem cells and promotes endothelial differentiation. Eur. J. Pharmacol. 591 (2008) 59-65
16. Kanno S., Kim P.K., Sallam K., Lei J., Billiar T.R., and Shears L.L. Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 101 (2004) 12277-12281
17. Feng Q., Song W., Lu X., Hamilton J.A., Lei M., Peng T., and Yee S.P. Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation 106 (2002) 873-879
18. Bloch W., Fleischmann B.K., Lorke D.E., Andressen C., Hops B., Hescheler J., and Addicks K. Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc. Res. 43 (1999) 675-684
19. Rebelatto C.K., Aguiar A.M., Moretão M.P., Senegaglia A.C., Hansen P., Barchiki F., Oliveira J., Martins J., Kuligovski C., Mansur F., Christofis A., Amaral V.F., Brofman P.S., Goldenberg S., Nakao L.S., and Correa A. Dissimilar differentiation potential of mesenchymal stem cells isolated from bone marrow, umbilical cord blood and adipose tissue. Exp. Biol. Med. 233 (2008) 901-913
20. Harlow E., and Lane D. Antibodies, A laboratory manual (1988), CSH Press, New York, USA
21. Seshi B., Kumar S., and King D. Multilineage gene expression in human bone marrow stromal cells as evidenced by single-cell microarray analysis. Blood Cells Mol. Dis. 31 (2003) 268-285
22. Gonzalez R., Maki C.B., Pacchiarotti J., Csontos S., Pham J.K., Slepko N., Patel A., and Silva F. Pluripotent marker expression and differentiation of human second trimester mesenchymal stem cells. Biochem. Biophys. Res. Commun. 362 (2007) 491-497
23. W.C. Lee, J.L. Sepulveda, J.P. Rubin, K.G. Marra, Cardiomyogenic differentiation potential of human adipose precursor cells, Int. J. Cardiol. (2008), doi: 10.1016/j.ijcard.2007.11.068.
24. Tondreau T., Lagneaux L., Dejeneffe M., Massy M., Mortier C., Delforge A., and Bron D. Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation. Differentiation 72 (2004) 319-326
25. Sampath P., Mazumder B., Seshadri V., Gerber C.A., Chavatte L., Kinter M., Ting S.M., Dignam J.D., Kim S., Driscoll D.M., and Fox P.L. Noncanonical function of glutamyl-prolyl-tRNA synthetase: gene-specific silencing of translation. Cell 119 (2004) 195-208
26. Ries C., Egea V., Karow M., Kolb H., Jochum M., and Neth P. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 109 (2007) 4055-4063
27. Wang C.H., Cherng W.J., Yang N.I., Kuo L.T., Hsu C.M., Yeh H.I., Lan Y.J., Yeh C.H., and Stanford W.L. Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 54-60
28. Girgenrath M., Weng S., Kostek C.A., Browning B., Wang M., Brown S.A., Winkles J.A., Michaelson J.S., Allaire N., Schneider P., Scott M.L., Hsu Y.M., Yagita H., Flavell R.A., Miller J.B., Burkly L.C., and Zheng T.S. TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. EMBO J. 25 (2006) 5826-5839
29. Coyne T.M., Marcus A.J., Woodbury D., and Black I.B. Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia. Stem Cells 24 (2006) 2483-2492
30. Davani S., Marandin A., Mersin N., Royer B., Kantelip B., Hervé P., Etievent J.P., and Kantelip J.P. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 108 Suppl. 1 (2003) II253-II258
31. Dai W., Hale S.L., Martin B.J., Kuang J.Q., Dow J.S., Wold L.E., and Kloner R.A. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112 (2005) 214-223
32. Suuronen E.J., Price J., Veinot J.P., Ascah K., Kapila V., Guo X.W., Wong S., Mesana T.G., and Ruel M. Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function. J. Thorac. Cardiovasc. Surg. 134 (2007) 1249-1258
33. Besse A., Trimoreau F., Praloran V., and Denizot Y. Effect of cytokines and growth factors on the macrophage colony-stimulating factor secretion by human bone marrow stromal cells. Cytokine 12 (2000) 522-525
34. Kamihata H., Matsubara H., Nishiue T., Fujiyama S., Tsutsumi Y., Ozono R., Masaki H., Mori Y., Iba O., Tateishi E., Kosaki A., Shitani S., Murohara T., Imaizumi T., and Iwasaka T. Implantation of bone-marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104 (2001) 1046-1052
35. Amano K., Matsubara H., Iba O., Okigaki M., Fujiyama S., Imada T., Kojima H., Nozawa Y., Kawashima S., Yokoyama M., and Iwasaka T. Enhancement of ischemia-induced angiogenesis by eNOS overexpression. Hypertension 41 (2003) 156-162
36. Su H., Lu R., and Kan Y.W. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Proc. Natl. Acad. Sci. USA 97 (2000) 13801-13806
37. Sato T., Laver J.H., and Ogawa M. Reversible expression of CD34 by murine hematopoietic stem cells. Blood 94 (1999) 2548-2554
38. Leone A.M., Rutella S., Bonanno G., Contemi A.M., de Ritis D.G., Giannico M.B., Rebuzzi A.G., Leone G., and Crea F. Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction. Int. J. Cardiol. 111 (2006) 202-208
39. Gaustad K.G., Boquest A.C., Anderson B.E., Gerdes A.M., and Collas P. Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytes. Biochem. Biophys. Res. Commun. 314 (2004) 420-427
40. Zaehres H., Lensch M.W., Daheron L., Stewart S.A., Itskovitz-Eldor J., and Daley G.Q. High-efficiency RNA interference in human embryonic stem cells. Stem Cells 23 (2005) 299-305
41. Chen Z., Evans W.H., Pflugfelder S.C., and Li D.Q. Gap junction protein connexin 43 serves as a negative marker for a stem cell-containing population of human limbal epithelial cells. Stem Cells 24 (2006) 1265-1273
42. Yoon B.S., Yoo S.J., Lee J.E., You S., Lee H.T., and Yoon H.S. Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment. Differentiation 74 (2006) 149-159